nodes	percent_of_prediction	percent_of_DWPC	metapath
Dabigatran etexilate—ABCB1—Naltrexone—alcohol dependence	0.182	0.601	CbGbCtD
Dabigatran etexilate—ABCB1—Citalopram—alcohol dependence	0.121	0.398	CbGbCtD
Dabigatran etexilate—Allergic oedema—Citalopram—alcohol dependence	0.017	0.0475	CcSEcCtD
Dabigatran etexilate—Injection site haemorrhage—Naltrexone—alcohol dependence	0.0115	0.0321	CcSEcCtD
Dabigatran etexilate—Surgery—Citalopram—alcohol dependence	0.00936	0.0261	CcSEcCtD
Dabigatran etexilate—Surgical intervention—Citalopram—alcohol dependence	0.00936	0.0261	CcSEcCtD
Dabigatran etexilate—Blood urine present—Citalopram—alcohol dependence	0.00832	0.0232	CcSEcCtD
Dabigatran etexilate—UGT2B15—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00685	0.0377	CbGpPWpGaD
Dabigatran etexilate—CES2—NRF2 pathway—ALDH3A1—alcohol dependence	0.00614	0.0338	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—pancreas—alcohol dependence	0.00594	0.0379	CbGeAlD
Dabigatran etexilate—ABCB1—Abacavir transport and metabolism—ADH1A—alcohol dependence	0.0059	0.0324	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—digestive system—alcohol dependence	0.00508	0.0323	CbGeAlD
Dabigatran etexilate—CES2—E2F transcription factor network—WASF1—alcohol dependence	0.00501	0.0275	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Biological oxidations—ADH6—alcohol dependence	0.00431	0.0237	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—ALDH3A1—alcohol dependence	0.00425	0.0234	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Phase II conjugation—GGT2—alcohol dependence	0.00423	0.0233	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—endocrine gland—alcohol dependence	0.00419	0.0267	CbGeAlD
Dabigatran etexilate—CES2—adrenal cortex—alcohol dependence	0.00409	0.0261	CbGeAlD
Dabigatran etexilate—NQO2—brainstem—alcohol dependence	0.00409	0.0261	CbGeAlD
Dabigatran etexilate—Abdominal discomfort—Disulfiram—alcohol dependence	0.004	0.0111	CcSEcCtD
Dabigatran etexilate—CES2—NRF2 pathway—ADH7—alcohol dependence	0.00396	0.0218	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—digestive system—alcohol dependence	0.00385	0.0245	CbGeAlD
Dabigatran etexilate—CES2—NRF2 pathway—GGT2—alcohol dependence	0.00379	0.0209	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—liver—alcohol dependence	0.00378	0.0241	CbGeAlD
Dabigatran etexilate—CES2—cardiovascular system—alcohol dependence	0.00374	0.0238	CbGeAlD
Dabigatran etexilate—Epigastric discomfort—Citalopram—alcohol dependence	0.00373	0.0104	CcSEcCtD
Dabigatran etexilate—NQO2—adrenal cortex—alcohol dependence	0.00366	0.0233	CbGeAlD
Dabigatran etexilate—CES2—pancreas—alcohol dependence	0.00363	0.0231	CbGeAlD
Dabigatran etexilate—Rectal haemorrhage—Acamprosate—alcohol dependence	0.00362	0.0101	CcSEcCtD
Dabigatran etexilate—CES1—NRF2 pathway—ALDH3A1—alcohol dependence	0.00362	0.0199	CbGpPWpGaD
Dabigatran etexilate—Hyperbilirubinaemia—Acamprosate—alcohol dependence	0.0036	0.01	CcSEcCtD
Dabigatran etexilate—UGT2B15—Biological oxidations—ADH1A—alcohol dependence	0.00357	0.0196	CbGpPWpGaD
Dabigatran etexilate—Gout—Acamprosate—alcohol dependence	0.0035	0.00978	CcSEcCtD
Dabigatran etexilate—Chest discomfort—Naltrexone—alcohol dependence	0.0035	0.00976	CcSEcCtD
Dabigatran etexilate—Gastrooesophageal reflux disease—Naltrexone—alcohol dependence	0.00343	0.00956	CcSEcCtD
Dabigatran etexilate—CES2—gonad—alcohol dependence	0.00339	0.0216	CbGeAlD
Dabigatran etexilate—F2—cardiovascular system—alcohol dependence	0.00335	0.0213	CbGeAlD
Dabigatran etexilate—Hepatic enzyme increased—Naltrexone—alcohol dependence	0.00327	0.00913	CcSEcCtD
Dabigatran etexilate—NQO2—pancreas—alcohol dependence	0.00324	0.0207	CbGeAlD
Dabigatran etexilate—UGT1A9—endocrine gland—alcohol dependence	0.00318	0.0203	CbGeAlD
Dabigatran etexilate—Haematoma—Citalopram—alcohol dependence	0.00312	0.00871	CcSEcCtD
Dabigatran etexilate—UGT2B7—Tamoxifen metabolism—CYP2E1—alcohol dependence	0.00312	0.0172	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—digestive system—alcohol dependence	0.0031	0.0198	CbGeAlD
Dabigatran etexilate—CES2—digestive system—alcohol dependence	0.0031	0.0198	CbGeAlD
Dabigatran etexilate—CES1—cardiovascular system—alcohol dependence	0.00308	0.0196	CbGeAlD
Dabigatran etexilate—UGT2B15—Biological oxidations—ADH4—alcohol dependence	0.00303	0.0167	CbGpPWpGaD
Dabigatran etexilate—Oesophagitis—Acamprosate—alcohol dependence	0.00299	0.00834	CcSEcCtD
Dabigatran etexilate—Ecchymosis—Acamprosate—alcohol dependence	0.00296	0.00825	CcSEcCtD
Dabigatran etexilate—CES2—blood—alcohol dependence	0.00295	0.0188	CbGeAlD
Dabigatran etexilate—CES1—E2F transcription factor network—WASF1—alcohol dependence	0.00295	0.0162	CbGpPWpGaD
Dabigatran etexilate—CES2—midbrain—alcohol dependence	0.00292	0.0186	CbGeAlD
Dabigatran etexilate—UGT1A9—liver—alcohol dependence	0.00287	0.0183	CbGeAlD
Dabigatran etexilate—Haemoglobin decreased—Citalopram—alcohol dependence	0.00285	0.00795	CcSEcCtD
Dabigatran etexilate—F2—digestive system—alcohol dependence	0.00278	0.0177	CbGeAlD
Dabigatran etexilate—Thrombosis—Citalopram—alcohol dependence	0.00277	0.00773	CcSEcCtD
Dabigatran etexilate—F2—blood—alcohol dependence	0.00265	0.0169	CbGeAlD
Dabigatran etexilate—NQO2—blood—alcohol dependence	0.00264	0.0168	CbGeAlD
Dabigatran etexilate—NQO2—midbrain—alcohol dependence	0.00261	0.0166	CbGeAlD
Dabigatran etexilate—UGT2B15—Biological oxidations—ADH7—alcohol dependence	0.00258	0.0142	CbGpPWpGaD
Dabigatran etexilate—CES2—endocrine gland—alcohol dependence	0.00256	0.0163	CbGeAlD
Dabigatran etexilate—UGT2B7—endocrine gland—alcohol dependence	0.00256	0.0163	CbGeAlD
Dabigatran etexilate—CES1—digestive system—alcohol dependence	0.00255	0.0163	CbGeAlD
Dabigatran etexilate—Cardiac failure congestive—Naltrexone—alcohol dependence	0.00248	0.00691	CcSEcCtD
Dabigatran etexilate—UGT2B15—Biological oxidations—GGT2—alcohol dependence	0.00247	0.0136	CbGpPWpGaD
Dabigatran etexilate—CES2—testis—alcohol dependence	0.00244	0.0156	CbGeAlD
Dabigatran etexilate—UGT2B7—testis—alcohol dependence	0.00244	0.0156	CbGeAlD
Dabigatran etexilate—Cardiac failure—Acamprosate—alcohol dependence	0.00243	0.00679	CcSEcCtD
Dabigatran etexilate—CES1—blood—alcohol dependence	0.00243	0.0155	CbGeAlD
Dabigatran etexilate—CES2—nervous system—alcohol dependence	0.0024	0.0153	CbGeAlD
Dabigatran etexilate—Gastrointestinal haemorrhage—Acamprosate—alcohol dependence	0.00238	0.00663	CcSEcCtD
Dabigatran etexilate—CES1—NRF2 pathway—ADH7—alcohol dependence	0.00233	0.0128	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—liver—alcohol dependence	0.00231	0.0147	CbGeAlD
Dabigatran etexilate—CES2—liver—alcohol dependence	0.00231	0.0147	CbGeAlD
Dabigatran etexilate—CES2—central nervous system—alcohol dependence	0.00231	0.0147	CbGeAlD
Dabigatran etexilate—F2—endocrine gland—alcohol dependence	0.0023	0.0146	CbGeAlD
Dabigatran etexilate—NQO2—endocrine gland—alcohol dependence	0.00229	0.0146	CbGeAlD
Dabigatran etexilate—UGT2B15—Biological oxidations—ADH1B—alcohol dependence	0.00226	0.0124	CbGpPWpGaD
Dabigatran etexilate—CES2—cerebellum—alcohol dependence	0.00226	0.0144	CbGeAlD
Dabigatran etexilate—Contusion—Citalopram—alcohol dependence	0.00225	0.00627	CcSEcCtD
Dabigatran etexilate—Gastrointestinal haemorrhage—Naltrexone—alcohol dependence	0.00225	0.00627	CcSEcCtD
Dabigatran etexilate—Pain in extremity—Naltrexone—alcohol dependence	0.00225	0.00627	CcSEcCtD
Dabigatran etexilate—CES1—NRF2 pathway—GGT2—alcohol dependence	0.00224	0.0123	CbGpPWpGaD
Dabigatran etexilate—Chest discomfort—Citalopram—alcohol dependence	0.00222	0.00619	CcSEcCtD
Dabigatran etexilate—Liver function test abnormal—Acamprosate—alcohol dependence	0.00219	0.00612	CcSEcCtD
Dabigatran etexilate—NQO2—testis—alcohol dependence	0.00218	0.0139	CbGeAlD
Dabigatran etexilate—Rectal haemorrhage—Citalopram—alcohol dependence	0.00217	0.00606	CcSEcCtD
Dabigatran etexilate—Bone disorder—Citalopram—alcohol dependence	0.00217	0.00606	CcSEcCtD
Dabigatran etexilate—Gastrooesophageal reflux disease—Citalopram—alcohol dependence	0.00217	0.00606	CcSEcCtD
Dabigatran etexilate—Hyperbilirubinaemia—Citalopram—alcohol dependence	0.00216	0.00602	CcSEcCtD
Dabigatran etexilate—F2—nervous system—alcohol dependence	0.00215	0.0137	CbGeAlD
Dabigatran etexilate—NQO2—nervous system—alcohol dependence	0.00214	0.0137	CbGeAlD
Dabigatran etexilate—Aspartate aminotransferase increased—Acamprosate—alcohol dependence	0.00214	0.00597	CcSEcCtD
Dabigatran etexilate—CES2—NRF2 pathway—SLC6A4—alcohol dependence	0.00214	0.0118	CbGpPWpGaD
Dabigatran etexilate—CES1—endocrine gland—alcohol dependence	0.00211	0.0134	CbGeAlD
Dabigatran etexilate—Gastritis—Acamprosate—alcohol dependence	0.0021	0.00587	CcSEcCtD
Dabigatran etexilate—Gout—Citalopram—alcohol dependence	0.0021	0.00586	CcSEcCtD
Dabigatran etexilate—Alanine aminotransferase increased—Acamprosate—alcohol dependence	0.00209	0.00585	CcSEcCtD
Dabigatran etexilate—UGT2B7—NRF2 pathway—ALDH3A1—alcohol dependence	0.00208	0.0114	CbGpPWpGaD
Dabigatran etexilate—Blood bilirubin increased—Citalopram—alcohol dependence	0.00207	0.00579	CcSEcCtD
Dabigatran etexilate—Hepatic enzyme increased—Citalopram—alcohol dependence	0.00207	0.00579	CcSEcCtD
Dabigatran etexilate—F2—liver—alcohol dependence	0.00207	0.0132	CbGeAlD
Dabigatran etexilate—F2—central nervous system—alcohol dependence	0.00207	0.0132	CbGeAlD
Dabigatran etexilate—F2—Selenium Micronutrient Network—GGT2—alcohol dependence	0.00206	0.0114	CbGpPWpGaD
Dabigatran etexilate—NQO2—liver—alcohol dependence	0.00206	0.0132	CbGeAlD
Dabigatran etexilate—NQO2—central nervous system—alcohol dependence	0.00206	0.0131	CbGeAlD
Dabigatran etexilate—Influenza—Acamprosate—alcohol dependence	0.00205	0.00573	CcSEcCtD
Dabigatran etexilate—Dysphagia—Acamprosate—alcohol dependence	0.00205	0.00573	CcSEcCtD
Dabigatran etexilate—Abdominal pain upper—Naltrexone—alcohol dependence	0.00205	0.00573	CcSEcCtD
Dabigatran etexilate—Fatigue—Disulfiram—alcohol dependence	0.00204	0.0057	CcSEcCtD
Dabigatran etexilate—Aspartate aminotransferase increased—Naltrexone—alcohol dependence	0.00202	0.00565	CcSEcCtD
Dabigatran etexilate—NQO2—cerebellum—alcohol dependence	0.00202	0.0128	CbGeAlD
Dabigatran etexilate—CES1—testis—alcohol dependence	0.00201	0.0128	CbGeAlD
Dabigatran etexilate—Nasopharyngitis—Naltrexone—alcohol dependence	0.00201	0.00561	CcSEcCtD
Dabigatran etexilate—Angina pectoris—Acamprosate—alcohol dependence	0.002	0.00558	CcSEcCtD
Dabigatran etexilate—UGT2B15—Phase II conjugation—GGT1—alcohol dependence	0.002	0.011	CbGpPWpGaD
Dabigatran etexilate—Musculoskeletal pain—Citalopram—alcohol dependence	0.00199	0.00554	CcSEcCtD
Dabigatran etexilate—Alanine aminotransferase increased—Naltrexone—alcohol dependence	0.00198	0.00553	CcSEcCtD
Dabigatran etexilate—CES1—nervous system—alcohol dependence	0.00197	0.0126	CbGeAlD
Dabigatran etexilate—Bronchitis—Acamprosate—alcohol dependence	0.00197	0.00551	CcSEcCtD
Dabigatran etexilate—UGT2B7—Biological oxidations—ADH6—alcohol dependence	0.00196	0.0108	CbGpPWpGaD
Dabigatran etexilate—Influenza—Naltrexone—alcohol dependence	0.00194	0.00542	CcSEcCtD
Dabigatran etexilate—UGT2B7—Phase II conjugation—GGT2—alcohol dependence	0.00193	0.0106	CbGpPWpGaD
Dabigatran etexilate—CES2—NRF2 pathway—SLC6A3—alcohol dependence	0.0019	0.0105	CbGpPWpGaD
Dabigatran etexilate—CES1—liver—alcohol dependence	0.0019	0.0121	CbGeAlD
Dabigatran etexilate—CES1—central nervous system—alcohol dependence	0.0019	0.0121	CbGeAlD
Dabigatran etexilate—Angina pectoris—Naltrexone—alcohol dependence	0.00189	0.00528	CcSEcCtD
Dabigatran etexilate—UGT2B15—Biological oxidations—MAOB—alcohol dependence	0.00187	0.0103	CbGpPWpGaD
Dabigatran etexilate—Bronchitis—Naltrexone—alcohol dependence	0.00187	0.00521	CcSEcCtD
Dabigatran etexilate—Abdominal discomfort—Naltrexone—alcohol dependence	0.00186	0.0052	CcSEcCtD
Dabigatran etexilate—Pneumonia—Acamprosate—alcohol dependence	0.00184	0.00514	CcSEcCtD
Dabigatran etexilate—CES2—brain—alcohol dependence	0.00183	0.0117	CbGeAlD
Dabigatran etexilate—Upper respiratory tract infection—Naltrexone—alcohol dependence	0.00181	0.00504	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Acamprosate—alcohol dependence	0.0018	0.00503	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Acamprosate—alcohol dependence	0.00179	0.00501	CcSEcCtD
Dabigatran etexilate—CES2—NRF2 pathway—GGT1—alcohol dependence	0.00179	0.00987	CbGpPWpGaD
Dabigatran etexilate—Oesophagitis—Citalopram—alcohol dependence	0.00179	0.005	CcSEcCtD
Dabigatran etexilate—Urinary tract infection—Acamprosate—alcohol dependence	0.00178	0.00496	CcSEcCtD
Dabigatran etexilate—Ecchymosis—Citalopram—alcohol dependence	0.00177	0.00495	CcSEcCtD
Dabigatran etexilate—Haematuria—Acamprosate—alcohol dependence	0.00175	0.00487	CcSEcCtD
Dabigatran etexilate—Pneumonia—Naltrexone—alcohol dependence	0.00174	0.00486	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Naltrexone—alcohol dependence	0.00173	0.00483	CcSEcCtD
Dabigatran etexilate—Infestation—Naltrexone—alcohol dependence	0.00173	0.00483	CcSEcCtD
Dabigatran etexilate—Epistaxis—Acamprosate—alcohol dependence	0.00173	0.00482	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Naltrexone—alcohol dependence	0.00171	0.00476	CcSEcCtD
Dabigatran etexilate—Asthenia—Disulfiram—alcohol dependence	0.0017	0.00474	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Naltrexone—alcohol dependence	0.0017	0.00474	CcSEcCtD
Dabigatran etexilate—UGT1A9—NRF2 pathway—ALDH3A1—alcohol dependence	0.00169	0.00929	CbGpPWpGaD
Dabigatran etexilate—Urinary tract infection—Naltrexone—alcohol dependence	0.00168	0.0047	CcSEcCtD
Dabigatran etexilate—ABCB1—Allograft Rejection—PECR—alcohol dependence	0.00167	0.00919	CbGpPWpGaD
Dabigatran etexilate—Haemoglobin—Acamprosate—alcohol dependence	0.00165	0.00461	CcSEcCtD
Dabigatran etexilate—F2—brain—alcohol dependence	0.00164	0.0105	CbGeAlD
Dabigatran etexilate—Haemorrhage—Acamprosate—alcohol dependence	0.00164	0.00459	CcSEcCtD
Dabigatran etexilate—NQO2—brain—alcohol dependence	0.00164	0.0104	CbGeAlD
Dabigatran etexilate—Hepatobiliary disease—Naltrexone—alcohol dependence	0.00164	0.00457	CcSEcCtD
Dabigatran etexilate—Epistaxis—Naltrexone—alcohol dependence	0.00163	0.00456	CcSEcCtD
Dabigatran etexilate—UGT2B7—Biological oxidations—ADH1A—alcohol dependence	0.00162	0.00894	CbGpPWpGaD
Dabigatran etexilate—Sinusitis—Naltrexone—alcohol dependence	0.00162	0.00453	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Acamprosate—alcohol dependence	0.00162	0.00452	CcSEcCtD
Dabigatran etexilate—UGT1A9—Biological oxidations—ADH6—alcohol dependence	0.00159	0.00877	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Biological oxidations—ALDH2—alcohol dependence	0.00159	0.00877	CbGpPWpGaD
Dabigatran etexilate—Dizziness—Disulfiram—alcohol dependence	0.00157	0.00437	CcSEcCtD
Dabigatran etexilate—UGT1A9—Phase II conjugation—GGT2—alcohol dependence	0.00156	0.00861	CbGpPWpGaD
Dabigatran etexilate—Connective tissue disorder—Naltrexone—alcohol dependence	0.00153	0.00426	CcSEcCtD
Dabigatran etexilate—CES1—brain—alcohol dependence	0.00151	0.00962	CbGeAlD
Dabigatran etexilate—Rash—Disulfiram—alcohol dependence	0.00149	0.00417	CcSEcCtD
Dabigatran etexilate—Headache—Disulfiram—alcohol dependence	0.00148	0.00414	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Acamprosate—alcohol dependence	0.00148	0.00414	CcSEcCtD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—OPRK1—alcohol dependence	0.00147	0.0081	CbGpPWpGaD
Dabigatran etexilate—Cardiac failure—Citalopram—alcohol dependence	0.00146	0.00407	CcSEcCtD
Dabigatran etexilate—Cardiac disorder—Naltrexone—alcohol dependence	0.00144	0.00403	CcSEcCtD
Dabigatran etexilate—Malnutrition—Acamprosate—alcohol dependence	0.00143	0.00399	CcSEcCtD
Dabigatran etexilate—Pain in extremity—Citalopram—alcohol dependence	0.00142	0.00397	CcSEcCtD
Dabigatran etexilate—Gastrointestinal haemorrhage—Citalopram—alcohol dependence	0.00142	0.00397	CcSEcCtD
Dabigatran etexilate—Osteoarthritis—Citalopram—alcohol dependence	0.00142	0.00397	CcSEcCtD
Dabigatran etexilate—Angiopathy—Naltrexone—alcohol dependence	0.00141	0.00394	CcSEcCtD
Dabigatran etexilate—Flatulence—Acamprosate—alcohol dependence	0.00141	0.00393	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Naltrexone—alcohol dependence	0.0014	0.00392	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Naltrexone—alcohol dependence	0.0014	0.00391	CcSEcCtD
Dabigatran etexilate—Back pain—Acamprosate—alcohol dependence	0.00138	0.00386	CcSEcCtD
Dabigatran etexilate—UGT2B7—Biological oxidations—ADH4—alcohol dependence	0.00138	0.0076	CbGpPWpGaD
Dabigatran etexilate—Malnutrition—Naltrexone—alcohol dependence	0.00135	0.00378	CcSEcCtD
Dabigatran etexilate—UGT2B7—NRF2 pathway—ADH7—alcohol dependence	0.00134	0.00737	CbGpPWpGaD
Dabigatran etexilate—Flatulence—Naltrexone—alcohol dependence	0.00133	0.00372	CcSEcCtD
Dabigatran etexilate—Anaemia—Acamprosate—alcohol dependence	0.00132	0.00369	CcSEcCtD
Dabigatran etexilate—UGT1A9—Biological oxidations—ADH1A—alcohol dependence	0.00132	0.00726	CbGpPWpGaD
Dabigatran etexilate—Liver function test abnormal—Citalopram—alcohol dependence	0.00131	0.00367	CcSEcCtD
Dabigatran etexilate—Back pain—Naltrexone—alcohol dependence	0.00131	0.00365	CcSEcCtD
Dabigatran etexilate—Angioedema—Acamprosate—alcohol dependence	0.00131	0.00365	CcSEcCtD
Dabigatran etexilate—Abdominal pain upper—Citalopram—alcohol dependence	0.0013	0.00363	CcSEcCtD
Dabigatran etexilate—UGT2B7—NRF2 pathway—GGT2—alcohol dependence	0.00128	0.00706	CbGpPWpGaD
Dabigatran etexilate—Syncope—Acamprosate—alcohol dependence	0.00128	0.00358	CcSEcCtD
Dabigatran etexilate—Aspartate aminotransferase increased—Citalopram—alcohol dependence	0.00128	0.00358	CcSEcCtD
Dabigatran etexilate—UGT2B15—Biological oxidations—CYP2E1—alcohol dependence	0.00127	0.00701	CbGpPWpGaD
Dabigatran etexilate—Nasopharyngitis—Citalopram—alcohol dependence	0.00127	0.00355	CcSEcCtD
Dabigatran etexilate—Palpitations—Acamprosate—alcohol dependence	0.00126	0.00353	CcSEcCtD
Dabigatran etexilate—Gastritis—Citalopram—alcohol dependence	0.00126	0.00352	CcSEcCtD
Dabigatran etexilate—CES1—NRF2 pathway—SLC6A4—alcohol dependence	0.00126	0.00693	CbGpPWpGaD
Dabigatran etexilate—Loss of consciousness—Acamprosate—alcohol dependence	0.00126	0.00351	CcSEcCtD
Dabigatran etexilate—Alanine aminotransferase increased—Citalopram—alcohol dependence	0.00126	0.0035	CcSEcCtD
Dabigatran etexilate—Cough—Acamprosate—alcohol dependence	0.00125	0.00348	CcSEcCtD
Dabigatran etexilate—Angioedema—Naltrexone—alcohol dependence	0.00124	0.00345	CcSEcCtD
Dabigatran etexilate—Hypertension—Acamprosate—alcohol dependence	0.00123	0.00345	CcSEcCtD
Dabigatran etexilate—Influenza—Citalopram—alcohol dependence	0.00123	0.00343	CcSEcCtD
Dabigatran etexilate—Dysphagia—Citalopram—alcohol dependence	0.00123	0.00343	CcSEcCtD
Dabigatran etexilate—Arthralgia—Acamprosate—alcohol dependence	0.00122	0.0034	CcSEcCtD
Dabigatran etexilate—Chest pain—Acamprosate—alcohol dependence	0.00122	0.0034	CcSEcCtD
Dabigatran etexilate—Syncope—Naltrexone—alcohol dependence	0.00121	0.00339	CcSEcCtD
Dabigatran etexilate—Bronchospasm—Citalopram—alcohol dependence	0.00121	0.00338	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00121	0.00337	CcSEcCtD
Dabigatran etexilate—CES2—E2F transcription factor network—EP300—alcohol dependence	0.00121	0.00665	CbGpPWpGaD
Dabigatran etexilate—Angina pectoris—Citalopram—alcohol dependence	0.0012	0.00335	CcSEcCtD
Dabigatran etexilate—Palpitations—Naltrexone—alcohol dependence	0.0012	0.00334	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Naltrexone—alcohol dependence	0.00119	0.00332	CcSEcCtD
Dabigatran etexilate—Bronchitis—Citalopram—alcohol dependence	0.00118	0.0033	CcSEcCtD
Dabigatran etexilate—Cough—Naltrexone—alcohol dependence	0.00118	0.0033	CcSEcCtD
Dabigatran etexilate—Abdominal discomfort—Citalopram—alcohol dependence	0.00118	0.00329	CcSEcCtD
Dabigatran etexilate—UGT2B7—Biological oxidations—ADH7—alcohol dependence	0.00117	0.00646	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Biological oxidations—GGT1—alcohol dependence	0.00117	0.00643	CbGpPWpGaD
Dabigatran etexilate—Hypertension—Naltrexone—alcohol dependence	0.00117	0.00326	CcSEcCtD
Dabigatran etexilate—Anaphylactic shock—Acamprosate—alcohol dependence	0.00117	0.00326	CcSEcCtD
Dabigatran etexilate—Infection—Acamprosate—alcohol dependence	0.00116	0.00324	CcSEcCtD
Dabigatran etexilate—Chest pain—Naltrexone—alcohol dependence	0.00115	0.00322	CcSEcCtD
Dabigatran etexilate—Arthralgia—Naltrexone—alcohol dependence	0.00115	0.00322	CcSEcCtD
Dabigatran etexilate—Shock—Acamprosate—alcohol dependence	0.00115	0.0032	CcSEcCtD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00114	0.00319	CcSEcCtD
Dabigatran etexilate—Upper respiratory tract infection—Citalopram—alcohol dependence	0.00114	0.00319	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Acamprosate—alcohol dependence	0.00114	0.00319	CcSEcCtD
Dabigatran etexilate—Skin disorder—Acamprosate—alcohol dependence	0.00113	0.00316	CcSEcCtD
Dabigatran etexilate—UGT2B7—Biological oxidations—GGT2—alcohol dependence	0.00113	0.0062	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Biological oxidations—ADH4—alcohol dependence	0.00112	0.00618	CbGpPWpGaD
Dabigatran etexilate—CES1—NRF2 pathway—SLC6A3—alcohol dependence	0.00112	0.00617	CbGpPWpGaD
Dabigatran etexilate—Anaphylactic shock—Naltrexone—alcohol dependence	0.0011	0.00308	CcSEcCtD
Dabigatran etexilate—Pneumonia—Citalopram—alcohol dependence	0.0011	0.00308	CcSEcCtD
Dabigatran etexilate—Infection—Naltrexone—alcohol dependence	0.0011	0.00306	CcSEcCtD
Dabigatran etexilate—Infestation—Citalopram—alcohol dependence	0.0011	0.00306	CcSEcCtD
Dabigatran etexilate—Infestation NOS—Citalopram—alcohol dependence	0.0011	0.00306	CcSEcCtD
Dabigatran etexilate—Hypotension—Acamprosate—alcohol dependence	0.00109	0.00304	CcSEcCtD
Dabigatran etexilate—UGT1A9—NRF2 pathway—ADH7—alcohol dependence	0.00109	0.00599	CbGpPWpGaD
Dabigatran etexilate—Shock—Naltrexone—alcohol dependence	0.00109	0.00303	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Naltrexone—alcohol dependence	0.00108	0.00302	CcSEcCtD
Dabigatran etexilate—Acute coronary syndrome—Citalopram—alcohol dependence	0.00108	0.00302	CcSEcCtD
Dabigatran etexilate—Myocardial infarction—Citalopram—alcohol dependence	0.00108	0.003	CcSEcCtD
Dabigatran etexilate—Skin disorder—Naltrexone—alcohol dependence	0.00107	0.00299	CcSEcCtD
Dabigatran etexilate—F2—Regulation of Actin Cytoskeleton—WASF2—alcohol dependence	0.00107	0.00589	CbGpPWpGaD
Dabigatran etexilate—Urinary tract infection—Citalopram—alcohol dependence	0.00107	0.00298	CcSEcCtD
Dabigatran etexilate—Musculoskeletal discomfort—Acamprosate—alcohol dependence	0.00106	0.00297	CcSEcCtD
Dabigatran etexilate—CES1—NRF2 pathway—GGT1—alcohol dependence	0.00106	0.00582	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Biological oxidations—MAOA—alcohol dependence	0.00105	0.00577	CbGpPWpGaD
Dabigatran etexilate—Haematuria—Citalopram—alcohol dependence	0.00105	0.00292	CcSEcCtD
Dabigatran etexilate—UGT1A9—NRF2 pathway—GGT2—alcohol dependence	0.00104	0.00574	CbGpPWpGaD
Dabigatran etexilate—Dyspnoea—Acamprosate—alcohol dependence	0.00104	0.0029	CcSEcCtD
Dabigatran etexilate—Hepatobiliary disease—Citalopram—alcohol dependence	0.00104	0.0029	CcSEcCtD
Dabigatran etexilate—Epistaxis—Citalopram—alcohol dependence	0.00103	0.00289	CcSEcCtD
Dabigatran etexilate—UGT2B7—Biological oxidations—ADH1B—alcohol dependence	0.00103	0.00567	CbGpPWpGaD
Dabigatran etexilate—Sinusitis—Citalopram—alcohol dependence	0.00103	0.00287	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Acamprosate—alcohol dependence	0.00103	0.00287	CcSEcCtD
Dabigatran etexilate—F2—Regulation of Actin Cytoskeleton—WASF1—alcohol dependence	0.00103	0.00565	CbGpPWpGaD
Dabigatran etexilate—Gastrointestinal disorder—Acamprosate—alcohol dependence	0.00101	0.00281	CcSEcCtD
Dabigatran etexilate—F2—Regulation of Actin Cytoskeleton—CHRM2—alcohol dependence	0.00101	0.00554	CbGpPWpGaD
Dabigatran etexilate—Musculoskeletal discomfort—Naltrexone—alcohol dependence	0.00101	0.00281	CcSEcCtD
Dabigatran etexilate—Constipation—Acamprosate—alcohol dependence	0.000998	0.00279	CcSEcCtD
Dabigatran etexilate—Haemoglobin—Citalopram—alcohol dependence	0.00099	0.00276	CcSEcCtD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—OPRD1—alcohol dependence	0.000989	0.00544	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—OPRK1—alcohol dependence	0.000987	0.00543	CbGpPWpGaD
Dabigatran etexilate—Haemorrhage—Citalopram—alcohol dependence	0.000985	0.00275	CcSEcCtD
Dabigatran etexilate—Dyspnoea—Naltrexone—alcohol dependence	0.000985	0.00275	CcSEcCtD
Dabigatran etexilate—F2—Selenium Micronutrient Network—GGT1—alcohol dependence	0.000976	0.00537	CbGpPWpGaD
Dabigatran etexilate—Urinary tract disorder—Citalopram—alcohol dependence	0.000973	0.00271	CcSEcCtD
Dabigatran etexilate—Oedema peripheral—Citalopram—alcohol dependence	0.00097	0.00271	CcSEcCtD
Dabigatran etexilate—Connective tissue disorder—Citalopram—alcohol dependence	0.000968	0.0027	CcSEcCtD
Dabigatran etexilate—Urethral disorder—Citalopram—alcohol dependence	0.000966	0.00269	CcSEcCtD
Dabigatran etexilate—UGT1A9—Biological oxidations—ADH7—alcohol dependence	0.000955	0.00525	CbGpPWpGaD
Dabigatran etexilate—Gastrointestinal pain—Acamprosate—alcohol dependence	0.000955	0.00266	CcSEcCtD
Dabigatran etexilate—Gastrointestinal disorder—Naltrexone—alcohol dependence	0.000954	0.00266	CcSEcCtD
Dabigatran etexilate—Fatigue—Naltrexone—alcohol dependence	0.000952	0.00266	CcSEcCtD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—PDYN—alcohol dependence	0.000948	0.00522	CbGpPWpGaD
Dabigatran etexilate—Constipation—Naltrexone—alcohol dependence	0.000944	0.00264	CcSEcCtD
Dabigatran etexilate—Urticaria—Acamprosate—alcohol dependence	0.000927	0.00259	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Acamprosate—alcohol dependence	0.000923	0.00258	CcSEcCtD
Dabigatran etexilate—UGT1A9—Biological oxidations—GGT2—alcohol dependence	0.000915	0.00504	CbGpPWpGaD
Dabigatran etexilate—Cardiac disorder—Citalopram—alcohol dependence	0.000914	0.00255	CcSEcCtD
Dabigatran etexilate—UGT2B7—Phase II conjugation—GGT1—alcohol dependence	0.000911	0.00501	CbGpPWpGaD
Dabigatran etexilate—Gastrointestinal pain—Naltrexone—alcohol dependence	0.000903	0.00252	CcSEcCtD
Dabigatran etexilate—Angiopathy—Citalopram—alcohol dependence	0.000894	0.00249	CcSEcCtD
Dabigatran etexilate—Immune system disorder—Citalopram—alcohol dependence	0.00089	0.00248	CcSEcCtD
Dabigatran etexilate—Mediastinal disorder—Citalopram—alcohol dependence	0.000888	0.00248	CcSEcCtD
Dabigatran etexilate—Urticaria—Naltrexone—alcohol dependence	0.000877	0.00245	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Naltrexone—alcohol dependence	0.000873	0.00244	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Acamprosate—alcohol dependence	0.00086	0.0024	CcSEcCtD
Dabigatran etexilate—Malnutrition—Citalopram—alcohol dependence	0.000857	0.00239	CcSEcCtD
Dabigatran etexilate—UGT2B7—Biological oxidations—MAOB—alcohol dependence	0.000854	0.0047	CbGpPWpGaD
Dabigatran etexilate—ABCB1—forebrain—alcohol dependence	0.000852	0.00543	CbGeAlD
Dabigatran etexilate—Flatulence—Citalopram—alcohol dependence	0.000845	0.00236	CcSEcCtD
Dabigatran etexilate—Asthenia—Acamprosate—alcohol dependence	0.000838	0.00234	CcSEcCtD
Dabigatran etexilate—UGT1A9—Biological oxidations—ADH1B—alcohol dependence	0.000837	0.00461	CbGpPWpGaD
Dabigatran etexilate—Back pain—Citalopram—alcohol dependence	0.000829	0.00231	CcSEcCtD
Dabigatran etexilate—Pruritus—Acamprosate—alcohol dependence	0.000826	0.0023	CcSEcCtD
Dabigatran etexilate—Hypersensitivity—Naltrexone—alcohol dependence	0.000814	0.00227	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Acamprosate—alcohol dependence	0.000799	0.00223	CcSEcCtD
Dabigatran etexilate—Anaemia—Citalopram—alcohol dependence	0.000793	0.00221	CcSEcCtD
Dabigatran etexilate—Asthenia—Naltrexone—alcohol dependence	0.000792	0.00221	CcSEcCtD
Dabigatran etexilate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—alcohol dependence	0.000791	0.00435	CbGpPWpGaD
Dabigatran etexilate—ABCB1—adrenal cortex—alcohol dependence	0.00079	0.00503	CbGeAlD
Dabigatran etexilate—Angioedema—Citalopram—alcohol dependence	0.000783	0.00219	CcSEcCtD
Dabigatran etexilate—Pruritus—Naltrexone—alcohol dependence	0.000781	0.00218	CcSEcCtD
Dabigatran etexilate—Dizziness—Acamprosate—alcohol dependence	0.000772	0.00215	CcSEcCtD
Dabigatran etexilate—Syncope—Citalopram—alcohol dependence	0.000769	0.00215	CcSEcCtD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—OPRM1—alcohol dependence	0.000761	0.00419	CbGpPWpGaD
Dabigatran etexilate—Palpitations—Citalopram—alcohol dependence	0.000758	0.00211	CcSEcCtD
Dabigatran etexilate—Diarrhoea—Naltrexone—alcohol dependence	0.000756	0.00211	CcSEcCtD
Dabigatran etexilate—Loss of consciousness—Citalopram—alcohol dependence	0.000754	0.0021	CcSEcCtD
Dabigatran etexilate—F2—GPCR ligand binding—OPRK1—alcohol dependence	0.000752	0.00414	CbGpPWpGaD
Dabigatran etexilate—Cough—Citalopram—alcohol dependence	0.000748	0.00209	CcSEcCtD
Dabigatran etexilate—Vomiting—Acamprosate—alcohol dependence	0.000742	0.00207	CcSEcCtD
Dabigatran etexilate—Hypertension—Citalopram—alcohol dependence	0.00074	0.00207	CcSEcCtD
Dabigatran etexilate—UGT1A9—Phase II conjugation—GGT1—alcohol dependence	0.00074	0.00407	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ADH6—alcohol dependence	0.000736	0.00405	CbGpPWpGaD
Dabigatran etexilate—Rash—Acamprosate—alcohol dependence	0.000736	0.00205	CcSEcCtD
Dabigatran etexilate—Dermatitis—Acamprosate—alcohol dependence	0.000735	0.00205	CcSEcCtD
Dabigatran etexilate—Headache—Acamprosate—alcohol dependence	0.000731	0.00204	CcSEcCtD
Dabigatran etexilate—Dizziness—Naltrexone—alcohol dependence	0.00073	0.00204	CcSEcCtD
Dabigatran etexilate—Chest pain—Citalopram—alcohol dependence	0.00073	0.00204	CcSEcCtD
Dabigatran etexilate—Arthralgia—Citalopram—alcohol dependence	0.00073	0.00204	CcSEcCtD
Dabigatran etexilate—UGT2B7—Biological oxidations—ALDH2—alcohol dependence	0.000726	0.00399	CbGpPWpGaD
Dabigatran etexilate—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.000725	0.00202	CcSEcCtD
Dabigatran etexilate—UGT2B7—NRF2 pathway—SLC6A4—alcohol dependence	0.000723	0.00398	CbGpPWpGaD
Dabigatran etexilate—ABCB1—cardiovascular system—alcohol dependence	0.00072	0.00459	CbGeAlD
Dabigatran etexilate—CES1—E2F transcription factor network—EP300—alcohol dependence	0.000713	0.00392	CbGpPWpGaD
Dabigatran etexilate—Vomiting—Naltrexone—alcohol dependence	0.000702	0.00196	CcSEcCtD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—NPY—alcohol dependence	0.0007	0.00385	CbGpPWpGaD
Dabigatran etexilate—ABCB1—pancreas—alcohol dependence	0.0007	0.00446	CbGeAlD
Dabigatran etexilate—Anaphylactic shock—Citalopram—alcohol dependence	0.0007	0.00195	CcSEcCtD
Dabigatran etexilate—Rash—Naltrexone—alcohol dependence	0.000696	0.00194	CcSEcCtD
Dabigatran etexilate—Dermatitis—Naltrexone—alcohol dependence	0.000696	0.00194	CcSEcCtD
Dabigatran etexilate—Infection—Citalopram—alcohol dependence	0.000695	0.00194	CcSEcCtD
Dabigatran etexilate—UGT1A9—Biological oxidations—MAOB—alcohol dependence	0.000694	0.00382	CbGpPWpGaD
Dabigatran etexilate—Nausea—Acamprosate—alcohol dependence	0.000693	0.00193	CcSEcCtD
Dabigatran etexilate—Headache—Naltrexone—alcohol dependence	0.000692	0.00193	CcSEcCtD
Dabigatran etexilate—Shock—Citalopram—alcohol dependence	0.000688	0.00192	CcSEcCtD
Dabigatran etexilate—Nervous system disorder—Citalopram—alcohol dependence	0.000686	0.00192	CcSEcCtD
Dabigatran etexilate—Thrombocytopenia—Citalopram—alcohol dependence	0.000685	0.00191	CcSEcCtD
Dabigatran etexilate—UGT2B15—Biological oxidations—POMC—alcohol dependence	0.000682	0.00375	CbGpPWpGaD
Dabigatran etexilate—Skin disorder—Citalopram—alcohol dependence	0.00068	0.0019	CcSEcCtD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—OPRD1—alcohol dependence	0.000663	0.00365	CbGpPWpGaD
Dabigatran etexilate—Nausea—Naltrexone—alcohol dependence	0.000656	0.00183	CcSEcCtD
Dabigatran etexilate—Hypotension—Citalopram—alcohol dependence	0.000654	0.00182	CcSEcCtD
Dabigatran etexilate—ABCB1—gonad—alcohol dependence	0.000654	0.00417	CbGeAlD
Dabigatran etexilate—UGT2B7—NRF2 pathway—SLC6A3—alcohol dependence	0.000645	0.00355	CbGpPWpGaD
Dabigatran etexilate—Musculoskeletal discomfort—Citalopram—alcohol dependence	0.000638	0.00178	CcSEcCtD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—PDYN—alcohol dependence	0.000636	0.0035	CbGpPWpGaD
Dabigatran etexilate—Dyspnoea—Citalopram—alcohol dependence	0.000624	0.00174	CcSEcCtD
Dabigatran etexilate—Dyspepsia—Citalopram—alcohol dependence	0.000616	0.00172	CcSEcCtD
Dabigatran etexilate—UGT2B15—Metabolism—ADH1A—alcohol dependence	0.00061	0.00336	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—NRF2 pathway—GGT1—alcohol dependence	0.000607	0.00334	CbGpPWpGaD
Dabigatran etexilate—Gastrointestinal disorder—Citalopram—alcohol dependence	0.000604	0.00169	CcSEcCtD
Dabigatran etexilate—Fatigue—Citalopram—alcohol dependence	0.000603	0.00168	CcSEcCtD
Dabigatran etexilate—Constipation—Citalopram—alcohol dependence	0.000598	0.00167	CcSEcCtD
Dabigatran etexilate—ABCB1—digestive system—alcohol dependence	0.000598	0.00381	CbGeAlD
Dabigatran etexilate—UGT1A9—Biological oxidations—ALDH2—alcohol dependence	0.00059	0.00324	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—SLC6A4—alcohol dependence	0.000588	0.00323	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Biological oxidations—CYP2E1—alcohol dependence	0.00058	0.00319	CbGpPWpGaD
Dabigatran etexilate—Gastrointestinal pain—Citalopram—alcohol dependence	0.000572	0.0016	CcSEcCtD
Dabigatran etexilate—UGT2B7—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000572	0.00315	CbGpPWpGaD
Dabigatran etexilate—ABCB1—blood—alcohol dependence	0.00057	0.00363	CbGeAlD
Dabigatran etexilate—ABCB1—midbrain—alcohol dependence	0.000563	0.00359	CbGeAlD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CHRM2—alcohol dependence	0.000556	0.00306	CbGpPWpGaD
Dabigatran etexilate—Urticaria—Citalopram—alcohol dependence	0.000556	0.00155	CcSEcCtD
Dabigatran etexilate—Abdominal pain—Citalopram—alcohol dependence	0.000553	0.00154	CcSEcCtD
Dabigatran etexilate—UGT2B7—Biological oxidations—GGT1—alcohol dependence	0.000533	0.00293	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—NRF2 pathway—SLC6A3—alcohol dependence	0.000524	0.00288	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ADH4—alcohol dependence	0.000519	0.00285	CbGpPWpGaD
Dabigatran etexilate—Hypersensitivity—Citalopram—alcohol dependence	0.000516	0.00144	CcSEcCtD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—OPRM1—alcohol dependence	0.00051	0.00281	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—OPRD1—alcohol dependence	0.000505	0.00278	CbGpPWpGaD
Dabigatran etexilate—Asthenia—Citalopram—alcohol dependence	0.000502	0.0014	CcSEcCtD
Dabigatran etexilate—Pruritus—Citalopram—alcohol dependence	0.000495	0.00138	CcSEcCtD
Dabigatran etexilate—ABCB1—endocrine gland—alcohol dependence	0.000494	0.00315	CbGeAlD
Dabigatran etexilate—UGT1A9—NRF2 pathway—GGT1—alcohol dependence	0.000494	0.00272	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—PDYN—alcohol dependence	0.000484	0.00266	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	0.000481	0.00265	CbGpPWpGaD
Dabigatran etexilate—Diarrhoea—Citalopram—alcohol dependence	0.000479	0.00134	CcSEcCtD
Dabigatran etexilate—UGT2B7—Biological oxidations—MAOA—alcohol dependence	0.000477	0.00263	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Biological oxidations—CYP2E1—alcohol dependence	0.000471	0.00259	CbGpPWpGaD
Dabigatran etexilate—ABCB1—testis—alcohol dependence	0.000471	0.003	CbGeAlD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—NPY—alcohol dependence	0.00047	0.00258	CbGpPWpGaD
Dabigatran etexilate—F2—G alpha (q) signalling events—AVP—alcohol dependence	0.000469	0.00258	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metapathway biotransformation—CYP2E1—alcohol dependence	0.000465	0.00256	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—AVP—alcohol dependence	0.000463	0.00255	CbGpPWpGaD
Dabigatran etexilate—Dizziness—Citalopram—alcohol dependence	0.000463	0.00129	CcSEcCtD
Dabigatran etexilate—ABCB1—nervous system—alcohol dependence	0.000463	0.00295	CbGeAlD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—HTR1B—alcohol dependence	0.000453	0.00249	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CRHR1—alcohol dependence	0.00045	0.00248	CbGpPWpGaD
Dabigatran etexilate—ABCB1—liver—alcohol dependence	0.000446	0.00284	CbGeAlD
Dabigatran etexilate—ABCB1—central nervous system—alcohol dependence	0.000445	0.00284	CbGeAlD
Dabigatran etexilate—Vomiting—Citalopram—alcohol dependence	0.000445	0.00124	CcSEcCtD
Dabigatran etexilate—Rash—Citalopram—alcohol dependence	0.000441	0.00123	CcSEcCtD
Dabigatran etexilate—UGT2B15—Metabolism—ADH7—alcohol dependence	0.000441	0.00243	CbGpPWpGaD
Dabigatran etexilate—Dermatitis—Citalopram—alcohol dependence	0.000441	0.00123	CcSEcCtD
Dabigatran etexilate—Headache—Citalopram—alcohol dependence	0.000438	0.00122	CcSEcCtD
Dabigatran etexilate—ABCB1—cerebellum—alcohol dependence	0.000435	0.00277	CbGeAlD
Dabigatran etexilate—UGT1A9—Biological oxidations—GGT1—alcohol dependence	0.000433	0.00238	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—OPRK1—alcohol dependence	0.000425	0.00234	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CHRM2—alcohol dependence	0.000423	0.00233	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GGT2—alcohol dependence	0.000423	0.00233	CbGpPWpGaD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—alcohol dependence	0.000419	0.00231	CbGpPWpGaD
Dabigatran etexilate—Nausea—Citalopram—alcohol dependence	0.000416	0.00116	CcSEcCtD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—DRD4—alcohol dependence	0.000396	0.00218	CbGpPWpGaD
Dabigatran etexilate—F2—G alpha (q) signalling events—HTR2A—alcohol dependence	0.00039	0.00215	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—OPRM1—alcohol dependence	0.000389	0.00214	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Biological oxidations—MAOA—alcohol dependence	0.000388	0.00213	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ADH1B—alcohol dependence	0.000387	0.00213	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—OPRK1—alcohol dependence	0.000386	0.00212	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—CNR1—alcohol dependence	0.000378	0.00208	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—HTR7—alcohol dependence	0.000369	0.00203	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—DRD2—alcohol dependence	0.000369	0.00203	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—NPY—alcohol dependence	0.000358	0.00197	CbGpPWpGaD
Dabigatran etexilate—ABCB1—brain—alcohol dependence	0.000354	0.00225	CbGeAlD
Dabigatran etexilate—F2—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—alcohol dependence	0.000349	0.00192	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CRH—alcohol dependence	0.000345	0.0019	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—HTR1B—alcohol dependence	0.000345	0.0019	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ADH6—alcohol dependence	0.000335	0.00184	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—MAOB—alcohol dependence	0.00032	0.00176	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Biological oxidations—POMC—alcohol dependence	0.000311	0.00171	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—AVP—alcohol dependence	0.000311	0.00171	CbGpPWpGaD
Dabigatran etexilate—F2—Peptide ligand-binding receptors—POMC—alcohol dependence	0.000308	0.00169	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—DRD4—alcohol dependence	0.000302	0.00166	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—CNR1—alcohol dependence	0.000288	0.00158	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—OPRD1—alcohol dependence	0.000285	0.00157	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—DRD2—alcohol dependence	0.000281	0.00155	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—HTR7—alcohol dependence	0.000281	0.00155	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ADH1A—alcohol dependence	0.000278	0.00153	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—PDYN—alcohol dependence	0.000274	0.00151	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ADH6—alcohol dependence	0.000273	0.0015	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—ALDH2—alcohol dependence	0.000273	0.0015	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—OPRD1—alcohol dependence	0.000259	0.00143	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—HTR2A—alcohol dependence	0.000258	0.00142	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CRHR1—alcohol dependence	0.000254	0.0014	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Biological oxidations—POMC—alcohol dependence	0.000253	0.00139	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—PDYN—alcohol dependence	0.000249	0.00137	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—PPARA activates gene expression—EP300—alcohol dependence	0.00024	0.00132	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CHRM2—alcohol dependence	0.000239	0.00132	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—AVP—alcohol dependence	0.000237	0.0013	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ADH4—alcohol dependence	0.000236	0.0013	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—alcohol dependence	0.000234	0.00129	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GOT2—alcohol dependence	0.000232	0.00127	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CRHR1—alcohol dependence	0.000231	0.00127	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—OPRK1—alcohol dependence	0.000228	0.00125	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ADH1A—alcohol dependence	0.000226	0.00124	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—OPRM1—alcohol dependence	0.00022	0.00121	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—CYP2E1—alcohol dependence	0.000218	0.0012	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CHRM2—alcohol dependence	0.000217	0.0012	CbGpPWpGaD
Dabigatran etexilate—F2—Class A/1 (Rhodopsin-like receptors)—POMC—alcohol dependence	0.000206	0.00114	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—NPY—alcohol dependence	0.000202	0.00111	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ADH7—alcohol dependence	0.000201	0.00111	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GOT1—alcohol dependence	0.0002	0.0011	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—GGT1—alcohol dependence	0.0002	0.0011	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—OPRM1—alcohol dependence	0.000199	0.0011	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—HTR2A—alcohol dependence	0.000197	0.00108	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CRH—alcohol dependence	0.000195	0.00107	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—HTR1B—alcohol dependence	0.000195	0.00107	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GGT2—alcohol dependence	0.000193	0.00106	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ADH4—alcohol dependence	0.000192	0.00106	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—NPY—alcohol dependence	0.000184	0.00101	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—MAOA—alcohol dependence	0.000179	0.000986	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CRH—alcohol dependence	0.000177	0.000974	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—HTR1B—alcohol dependence	0.000177	0.000974	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ADH1B—alcohol dependence	0.000176	0.000969	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—DRD4—alcohol dependence	0.00017	0.000938	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	0.000166	0.000914	CbGpPWpGaD
Dabigatran etexilate—ABCB1—HIF-1-alpha transcription factor network—EP300—alcohol dependence	0.000165	0.00091	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ADH7—alcohol dependence	0.000163	0.000898	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—CNR1—alcohol dependence	0.000163	0.000896	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—alcohol dependence	0.000162	0.000889	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	0.00016	0.00088	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—HTR7—alcohol dependence	0.000159	0.000874	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—DRD2—alcohol dependence	0.000159	0.000874	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR ligand binding—POMC—alcohol dependence	0.000157	0.000865	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GGT2—alcohol dependence	0.000157	0.000861	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—DRD4—alcohol dependence	0.000155	0.000852	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—OPRD1—alcohol dependence	0.000153	0.000843	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—CNR1—alcohol dependence	0.000148	0.000813	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—PDYN—alcohol dependence	0.000147	0.000808	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—MAOB—alcohol dependence	0.000146	0.000803	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—DRD2—alcohol dependence	0.000144	0.000793	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—HTR7—alcohol dependence	0.000144	0.000793	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ADH1B—alcohol dependence	0.000143	0.000788	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—WASF2—alcohol dependence	0.000137	0.000751	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CRHR1—alcohol dependence	0.000137	0.000751	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	0.000136	0.000748	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—AVP—alcohol dependence	0.000134	0.000735	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—WASF1—alcohol dependence	0.000131	0.00072	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CHRM2—alcohol dependence	0.000128	0.000706	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ADH6—alcohol dependence	0.000125	0.000688	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—ALDH2—alcohol dependence	0.000124	0.000683	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—AVP—alcohol dependence	0.000121	0.000668	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—MAOB—alcohol dependence	0.000119	0.000653	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—OPRM1—alcohol dependence	0.000118	0.000648	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—POMC—alcohol dependence	0.000117	0.000642	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—HTR2A—alcohol dependence	0.000111	0.000612	CbGpPWpGaD
Dabigatran etexilate—F2—Metabolism of proteins—POMC—alcohol dependence	0.000111	0.000608	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—NPY—alcohol dependence	0.000108	0.000597	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GOT2—alcohol dependence	0.000106	0.000581	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HTR1B—alcohol dependence	0.000105	0.000576	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CRH—alcohol dependence	0.000105	0.000576	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ADH1A—alcohol dependence	0.000104	0.00057	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—HTR2A—alcohol dependence	0.000101	0.000556	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—ALDH2—alcohol dependence	0.000101	0.000555	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—CYP2E1—alcohol dependence	9.92e-05	0.000546	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	9.7e-05	0.000534	CbGpPWpGaD
Dabigatran etexilate—F2—Hemostasis—EP300—alcohol dependence	9.32e-05	0.000513	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—DRD4—alcohol dependence	9.14e-05	0.000503	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GGT1—alcohol dependence	9.11e-05	0.000501	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—GOT1—alcohol dependence	9.11e-05	0.000501	CbGpPWpGaD
Dabigatran etexilate—F2—GPCR downstream signaling—POMC—alcohol dependence	8.88e-05	0.000489	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ADH4—alcohol dependence	8.81e-05	0.000485	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—CNR1—alcohol dependence	8.73e-05	0.00048	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GOT2—alcohol dependence	8.58e-05	0.000472	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HTR7—alcohol dependence	8.52e-05	0.000469	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—DRD2—alcohol dependence	8.52e-05	0.000469	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—MAOA—alcohol dependence	8.16e-05	0.000449	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling by GPCR—POMC—alcohol dependence	8.07e-05	0.000444	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—CYP2E1—alcohol dependence	8.06e-05	0.000444	CbGpPWpGaD
Dabigatran etexilate—UGT2B15—Metabolism—EP300—alcohol dependence	7.74e-05	0.000426	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	7.7e-05	0.000423	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ADH7—alcohol dependence	7.49e-05	0.000412	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GGT1—alcohol dependence	7.4e-05	0.000407	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—GOT1—alcohol dependence	7.4e-05	0.000407	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GGT2—alcohol dependence	7.18e-05	0.000395	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—AVP—alcohol dependence	7.17e-05	0.000395	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	7.07e-05	0.000389	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—MAOA—alcohol dependence	6.63e-05	0.000365	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ADH1B—alcohol dependence	6.57e-05	0.000361	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	6.43e-05	0.000354	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	6.37e-05	0.00035	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—HTR2A—alcohol dependence	5.97e-05	0.000328	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—MAOB—alcohol dependence	5.44e-05	0.000299	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—POMC—alcohol dependence	5.31e-05	0.000292	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—POMC—alcohol dependence	4.77e-05	0.000262	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—ALDH2—alcohol dependence	4.63e-05	0.000255	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—POMC—alcohol dependence	4.32e-05	0.000238	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GOT2—alcohol dependence	3.93e-05	0.000216	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—CYP2E1—alcohol dependence	3.7e-05	0.000203	CbGpPWpGaD
Dabigatran etexilate—UGT2B7—Metabolism—EP300—alcohol dependence	3.53e-05	0.000194	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GGT1—alcohol dependence	3.4e-05	0.000187	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—GOT1—alcohol dependence	3.4e-05	0.000187	CbGpPWpGaD
Dabigatran etexilate—F2—Signaling Pathways—EP300—alcohol dependence	3.16e-05	0.000174	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—MAOA—alcohol dependence	3.04e-05	0.000167	CbGpPWpGaD
Dabigatran etexilate—UGT1A9—Metabolism—EP300—alcohol dependence	2.87e-05	0.000158	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—POMC—alcohol dependence	1.98e-05	0.000109	CbGpPWpGaD
Dabigatran etexilate—ABCB1—Metabolism—EP300—alcohol dependence	1.31e-05	7.23e-05	CbGpPWpGaD
